Elan Corporation Plc
New York, New York (New York) US
Business consulting, nec, Other Management Consulting Services...
TEL: 2124075740
http://www.elan.ie
Total : 2 View more »
New York, New York (New York) US
Business consulting, nec, Other Management Consulting Services...
TEL: 2124075740
http://www.elan.ie
Total : 160 View more »
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory
Directory of Approved network cabling installation companies. Browse through a range of network cabling installation firms, or sign up and get your own network cabling installation company listed (subject to Approval).
http://www.approvedindex.co.uk/indexes/NetworkInstallation/uk-companies/directory.aspx?page=2
Elan Microelectronics expects to ship 500,000-600,000 touchscreen ICs used in handsets in the fourth quarter, about three times the volume it shipped in the third quarter. However, the company estimates its fourth-quarter revenues will drop 8-16% to NT$1.1-1.2 billion (US$34.02-37.11 million) due
J&J on Thursday closed its deal to buy a stake in Elan for $885 million and obtain rights to the biotech company's Alzheimer's disease treatment program.
http://www.manufacturing.net/News-Johnson-Johnson-Closes-Deal-For-Elan-091709.aspx
Total : 74 View more »
Nov 13, 2009 (Close-Up Media via COMTEX) --
Elan Corp. has announced that it will present at the Lazard Capital Markets 6th Annual Healthcare Conference, on Tuesday, November 17, at 9:55 a.m. Eastern Time and 2:55 p.m. GMT.
Interested parties may access a live audio web cast of the presentation by visiting the Investor Relations section of the Elan website at elan.com, then clicking on the event icon. Following the live webcast, an archived version of the presentation will be available at the same URL.
Elan Corp. is a neuroscience-based biotechnology company.
((Comments on this story may be sent to health@closeupmedia.com))
Tags: biotechnology conference health nervous system web
Companies: Elan Corp. Plc (ELN)
Nov 10, 2009 (Fresh Brewed Media via COMTEX) --
Elan Corp (ELN) could be on the move today and is now at $6.33, down $0.18 (-2.76%) on volume of 6,798,580 shares traded. Over the last 52 weeks the stock has ranged from a low of $4.61 to a high of $9.13. Elan Corp stock has been showing support around $6.09 and resistance in the $6.77 range. Technical indicators for the stock are neutral and S&P gives ELN a neutral 3 STARS (out of 5) hold ranking. If you are looking for a hedged play on ELN the stock seems like it could be a candidate for a January out-of-the-money bear-call credit spread above the 7.50 range.
ABR-Seven Summits Strategic Investments NewsBite Goto www.iotogo.com/18w1 for our free report titled, The 18 Ways To Know When It's Time To Dump A Stock
Tags: S&P
Companies: Elan Corp. Plc (ELN)
DUBLIN, Ireland, Nov 10, 2009 (BUSINESS WIRE) --
Elan Corporation, plc (NYSE: ELN) today announced that it will present at the Lazard Capital Markets 6th Annual Healthcare Conference, on Tuesday, November 17, 2009 at; 9:55 a.m. Eastern Time and 2:55 p.m. GMT.
Interested parties may access a live audio web cast of the presentation by visiting the Investor Relations section of the Elan website at www.elan.com, then clicking on the event icon. Following the live webcast, an archived version of the presentation will be available at the same URL.
About Elan
Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. Elan shares trade on the New York and Irish Stock Exchanges. For additional information about the company, please visit http://www.elan.com.
SOURCE: Elan Corporation, plc
Elan Corporation, plc MEDIA: Mary Stutts, 650 794 4403 Niamh Lyons, 353-1-663-3602 or INVESTORS: Chris Burns, 800 252 3526 David Marshall, 353 1 709 4444
Tags: biotechnology conference medical nervous system nyse science trade web
Companies: Elan Corp. Plc (ELN)
Nov 06, 2009 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend, our proprietary pattern recognition system, called a Downtrend for Elan (NYSE:ELN) on June 30, 2009 at $6.53.
Since then, Elan has returned 5.7% as of today's recent price of $6.15. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nyse profit securities trial
Companies: Elan Corp. Plc (ELN)
Total : 5,210 View more »
© 2006-2009 Airplane-Pictures.net - Photos | News | Forums All photos are copyright © to their respective photographers and may not be used without permission. Terms and Conditions | Photo Use | Privacy Policy | About | RSS | E-mail us: Team@Airplane-Pictures.net
Elan Consulting Ltd.; 950 Third Avenue, 18th Floor; New York, NY 10022; United States Telephone: +1 (212) 319.1033; Telecopier: +1 (212) 750.0101; e-mail: postmaster@elanconsulting.
ELAN Home Systems capped its highly successful "Takin' it to the Streets" 2009 North American road show with an industry first YouTube.com drawing for over $30,000 in prizes for its dealers.
Aircraft Photo by Malcolm Clarke, G-CKJH, 2004 Ams-flight Doo DG-303, Glaser-Dirks DG-300 Elan at the Yorkshire Gliding Club, Sutton Bank, UK, England
Total : 6,200,000 View more »
Develops drugs and drug-delivery systems through its subsidiaries. Includes investor information, news and careers, with facilities through the USA, headquartered in Dublin ...
Get the latest on Elan Corporation, plc (ADR) including up to date news, high quality discussion groups and more on Google Finance.
Elan Corporation PLC. The Group's principal activity is discovering, developing, manufacturing and marketing advanced therapies in neurodegenerative diseases, autoimmune diseases ...
http://www.corporateinformation.com/Company-Snapshot.aspx?cusip=C372CQ960
Elan Corporation, plc operates as a neuroscience-based biotechnology company primarily in Ireland and the United States. It operates in two segments, Biopharmaceuticals and Elan ...
Insurance jobs in Netherlands at CWJobs.co.uk. Apply online for your next job in IT.
http://www.cwjobs.co.uk/JobSeeking/Insurance_Netherlands_l1794_t4.html
Für unseren Kunden, ein international tätiges Unternehmen, suchen wir in Bern einen TIBCO Spezialist. Unser Kunde sucht hierbei einen Junior der bereits Erfahrung mit TIBCO hat und einen Senior TIBCO Spezialisten. Ihre Aufgaben: Als TIBCO Spezialist sind Sie Teil des Webteams und betreuen d ...
Computing jobs in Netherlands at CWJobs.co.uk. Apply online for your next job in IT.
http://www.cwjobs.co.uk/JobSeeking/Computing_Netherlands_l1794_t4.html
Computing jobs in Avon at CWJobs.co.uk. Apply online for your next job in IT.
http://www.cwjobs.co.uk/JobSeeking/Computing_Avon_l10001_t2.html
Navigation [accesskey 1] Content [accesskey 2] Site Search [accesskey 3] Job Seekers Login [accesskey 4] top of page [accesskey 5] PharmiWeb.com, From PharmiWeb Solutions PharmiWeb.com from PharmiWeb Solutions PharmiWeb.com Home Page 19 June 2008 Select a company 1st Pharma People 20:20 Selection
http://www.pharmiweb.com/events/event.asp?eventId=4133&channel=2
CB Technologies is a leading provider of electronic clinical intelligence tools, e-business consulting, and integration services for the life science industries. CB is headquartered in West Chester, PA, with offices in Boston, MA, and San Francisco, CA.
http://www.smi-online.co.uk/event_media/sponsors.asp?is=4&ref=212
Oncology RD is currently booming with pharmaceuticals on a quest to develop effective cancer drugs. The established standard of care – surgery, radiotherapy and chemotherapy is fast giving way to a high-tech array of targeted therapies.
http://www.pharmiweb.com/events/event.asp?eventId=4023§ion=howto